Novo Nordisk NVO announced a significant partnership with Septerna SEPN, a U.S.-based biotech company, valued at up to $2.2 billion, to tap the growing obesity treatment market. F ...

Drugmaker Abbott India reported a 28% rise in fourth-quarter profit on Thursday, helped by strong demand for its ...

Zacks.com users have been paying close attention to Novo Nordisk (NVO). This makes it worthwhile to examine what the stock has in store.

Q1 2025 Earnings Call Transcript May 13, 2025 Lexicon Pharmaceuticals, Inc. beats earnings expectations. Reported EPS is ...

Pakistan’s pharmaceutical retail market reached Rs. 1.049 trillion in sales for the 12 months ending March 2025, reflecting a ...

CompanyOverview|NYSE:NVO] Despite a double beat in its quarterly earnings on May 7, Novo Nordisk A/S (NYSE: NVO) stock is ...

U.S.-based Waters Corp , which makes medical equipment used in clinical testing, has seen a spurt in demand from drugmakers ...

Novo Nordisk's current product portfolio is well-protected by patents until at least 2030. Click here to see why NVO stock is ...

Denmark’s economic growth, which was driven by what economists described as an “exceptional surge” in pharmaceutical exports, ...